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cohort. In other studies of children born in 1966 to 1973, the
frequency of cerebral palsy among survivors was also quite
low. 17-20
The eyes of all study infants were repeatedly examined in
the nurseries by an ophthalmologist. 5 of the children were
blind, 3 because of cicatricial retrolental fibroplasia (RLF).
The prevalence of severe bilateral visual impairment (2 - 107o)
is calculated on the basis of the numbers seen at the age of 2
years by an ophthalmologist. However, since all but 2 of the
other children were examined by a paediatrician at this age
visual defect of this degree was unlikely to remain
unsuspected, and the probable prevalence of blindness
among survivors is 1 - 7%. This finding confirms that RLF
remains a significant problem; these and the less serious
ocular abnormalities have been reported separately.13,14
Severe sensorineural deafness requiring a hearing aid was
identified in only 4 children, although many parents would
not bring their children for testing. Those not formally
assessed at 2 years of age had no speech or language problems
and in most, free-field audiometry had been performed earlier
in infancy; conductive hearing impairment, abnormal
tympanograms, and abnormal tympanic membranes on
clinical examination were frequent findings. A prevalence of
severe sensorineural deafness of I’ 5% is considered to be an
accurate estimate. This rate is an improvement on the level of
3-7% reported for the 1966-70 cohort of VLBW infants
from hospital A. 16 
’
18 0% of the entire cohort were classified as having one or
more major handicap; all children with cerebral palsy were
included in this category so that our data would be
comparable to those in other reports. Unfortunately, there is
no uniform definition of major handicap: a more realistic
appraisal of our cohort would be achieved by excluding the 12
children with mild cerebral palsy and an MDI or Stanford-
Binet score above 78, but including in the severely
handicapped category 1 girl with arthrogryposis. With these
adjustments, 43 (14-4%) children have a moderate or severe
functional handicap. Some children were classified as
handicapped solely because ofa low MDI, but in each of these
children, the independent paediatric assessment also
indicated severe developmental delay.
In children aged 2 years handicaps likely to result in
permanent disability can be identified with reasonable
accuracy. It is too early to assess the prevalence of mild
handicap in the remainder of the children; assessment at
primary school age will be necessary to obtain this
information.
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Round the World
From our Correspondents
West Germany
ATTITUDES TO CONTROLLED CLINICAL TRIALS
ASK a German doctor whether the controlled trial is an essential
aid to clinical work and the answer is unlikely to be a firm Yes. Most
have had no undergraduate or postgraduate training in the
subject-or even experience in the ethically much less problematical
matter of designing work in animals for the M.D. thesis. Now, in
professional life, the doctor is a prey, week by week, to sharply
conflicting news and views.
On the one hand, controlled trials are seen as praiseworthy in
being "scientific"; they are mustered in support of some 400 drugs
registered every year by the German drug regulatory authority; I
they are recommended by the main scientific societies;2,3 they are
invoked by drug companies ("a controlled trial has shown ...
and they are at least not excluded by German law (Arzneimit-
telgesetz, 1978).
On the other hand, at least six reasons are advanced for rejection of
controlled trials. They have come under fire from some American
workers (again, the voice of sciences The activities of participating
doctors have been compared by the Press with those of concentra-
tion-camp criminals ("human sacrifice, medical technocrats"), and
such taunts are not easily countered by lone research-workers. More
seriously, a single instance of death in the control group of a trial has
been categorised by a professor of criminal law as assassination,6 6
and ten court cases are under way against the conductors of trials. 7
The sheer number of trials (3-5 per substance) is said to contribute
to an anonymous, mass produced, and heartless medical system; and
for this and other reasons they have been assailed by critics within
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the profession,8,9 whose. impact derives partly from the public
distaste for "authority". Last but not least, controlled clinical trials
are rejected by the manufacturers of products which lack activity
("We help the individual subject, not the masses").
There is no simple answer to these philosophical and practical
dilemmas, but some guidance is on offer. 2,10,11 Firstly, more
intellectual power should be devoted to the clinical aspects of a trial.
Whereas statistical, legal, and ethical aspects now receive ample, if
not undue, attention, clinical trials often fail because relevant
existing information has been neglected, because clinically
unimportant end-points have been selected and known prognostic
factors omitted, because clinical pharmacology has been ignored,
because the methods of assessment are imprecise, because follow-up
is incomplete, and because quality control is lacking. Not every
clinical question has to be answered by a placebo-controlled trial.
Clinical trials fall into different categories, and the distinction is
relevant to the question of informed consent. Placebo controls
apart, there is the comparison of two standard treatments, the
comparison of an advanced new therapeutic or diagnostic regimen
with routine management, and the trial involving human
experimentation (such as heart transplantation). For trials of
standard treatments administered routinely, informed consent
about randomisation is not considered absolutely necessary. 11 *
Remarkably, the first West German workshop on clinical trials
was established by the Surgical Society; and this trend is reflected in
the establishment of a chair of theoretical surgery at Marburg. -
Department of Theoretical Surgery,
University of Marburg (Lahn),
Federal Republic of Germany W. LORENZ
United States
SENATOR KENNEDY AND A NUCLEAR FREEZE
THE latest Gallup opinion poll shows Democrats across the
nation strongly favour Senator Edward Kennedy as their party’s
Presidential nominee in 1984. In accordance with custom, Mr
Kennedy won’t say this early whether he will run for it again. There
is more pressing business at hand, anyway. His 1982 re-election
campaign in Massachusetts for another six-year term in the U.S.
Senate begins in July. This promises to be a rigorous effort, even
though the Senator’s likely Republican opponent, Mr Raymond
Shamie, is a political unknown. A wealthy businessman, Mr Shamie
is said to have collected$4 million to help correct his problem of
name recognition. Furthermore, Mr Shamie’s polls say Mr
Kennedy’s popularity is in decline (another poll disputes this).
Whatever Mr Kennedy’s Presidential ambitions, politicians will
be watching this contest as a preview of his performance potential
for 1984. Of special relevance will be one of Mr Kennedy’s favourite
political issues: his proposal, along with a Republican co-sponsor,
Senator Mark O. Hatfield of Oregon, for the United States to enter
an agreement with the Soviet Union to freeze the testing,
production, and development of nuclear weapons and new aircraft
designed to deliver nuclear weapons. This proposal lacks the
necessary White House and Congressional support to achieve
reality, but there are indications of widespread popular support.
Town meetings and city councils around the country have approved
their local version of a freeze proposal. A freeze will be on the
November ballot in California and other states. Surveys indicate
that 60-70% of the population favour a freeze.
Mr Reagan and leaders in Congress say a freeze now is out of the
question. They say it would freeze the arms buildup at a point
favourable to the Soviet Union; they appear to suggest the idea is
simplistic. They are, however, handling the matter with extreme
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caution. Voters do not like to be told it is all too complicated for them
to understand. So Mr Reagan and his supporters get around it by
saying they, too, are for a freeze-after the current$1 - 5 trillion arms
buildup is completed. Senator Kennedy has this comment: "The
President says, in effect, that we have to build more nuclear bombs
today in order to reduce the number of bombs tomorrow. That is
voodoo arms control."
What is remarkable about all this is that Mr Kennedy, less than
two years after his party decisively rejected his bid for the
Presidential nomination, is again on the offensive. Actually, Mr
Kennedy’s ideas have not changed. The times have changed. Many
people are more worried about nuclear war than they were two years
ago. The President, along with Secretary of Defense Caspar W.
Weinberger and Secretary of State Alexander M. Haig Jr, have
inferentially acknowledged these fears in the public by toning down
or foregoing altogether previously bellicose, threatening language.
Even more directly, people are dismayed over the depressed
economy with its record high unemployment levels, business
failures, farm discontent, and high interest rates. Republican Wall
Street seems uneasy.
The conservative nature of the U.S. electorate should never be
discounted. Americans tend to vote heavily against candidates on
the left, such as George McGovern, or on the right, such as Barry
Goldwater, when they suspect that any strong deviation from the
status quo is contemplated. A candidate with the name and Irish
charm of Edward Kennedy, however, is something else again, even
if he does sound like George McGovern. If the current political
mood persists or intensifies, Senator Kennedy might be a strong
contender for the Presidency in 1984.
QUESTIONS ABOUT THE DEPARTMENT OF AGRICULTURE
THERE are some disturbing events in the Department of
Agriculture under the present Administration. A report from the
Department has recommended that, in the appointment of advisers
to examine scientific research applications, it was advisable to
consider their political views and affiliations and to suggest only
individuals whose views correspond with those of the present
administration. This was an astonishing suggestion in a democratic
country, in which scorn has often been expressed for the pretensions
of Soviet "science" in the days of Stalin. Immediate criticism was
forthcoming from scientists of all shades of opinion and the report
was promptly recalled and disavowed by the Secretary for
Agriculture.
But suspicions that there are strange influences in the
Department have been increased by the controversy in the
American Dietetic Association over its relationship to the
Department. The Association had been protesting against the
Administration’s proposals over the deregulation of nursing homes.
The Association’s leaders supported President Reagan’s cuts in
food stamps and school meals, to the fury of many members, and this
disquiet has been rekindled by the proposal that the Association
should take over the publication of the Department of Agriculture’s
new book on food. One might have thought this a sound move, did
one not know of the controversy over this publication. One chapter
deals with weight reduction and others on how this might be
achieved by a reduction in the consumption of fat, fatty products,
eggs, and milk, with suitable menus to accomplish these ends. The
Department intended to publish the book, but there was internal
opposition, as well as intensive lobbying by the meat, egg, and dairy
producers. Indeed the Under-Secretary, a past president of the
American Meat Institute, said it would be published only "over my
dead body". Whether to prevent his demise or not, the Department
found that it had not the funds to publish the book. Perhaps the
reaction of the public was anticipated, for, since the reduction in
deaths from heart disease and strokes is widely attributed to just
those measures that it was decided to cut out of the book, severe
criticisms might be expected. The Association now wants to publish
the book but without the information on fat and cholesterol, so that
the public will be advised to eat meat for breakfast, perhaps with
eggs. These events are aggravating some members of the
Association and raising some questions about the advice given to the
Administration and the influences brought to bear on the
Department’s decisions.
